Villaganas, Ruthelia S.
HRN: 21-29-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2022
CEFTAZIDIME 1GM (VIAL)
05/27/2022
06/02/2022
IV INFUSION
1g
Q8
CAP
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes